Kidney failure
Therapeutic area
Nephrology
Rare disease
No
- Definition
- An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Kidney failure
- Therapeutic area
- Nephrology
- kidney failure
- failure, renal
- renal failure
- renal failure syndrome
- renal insufficiency
- All therapeutic areas
- Nephrology
- Severity
- Severe
- MONDO ID
- MONDO:0001106
- Parent condition
- MONDO:0005240
Related records
Broader conditions (5)
- Disease
- Disease by body system or component
- Human disease
- Kidney disorder
- Urinary system disorder
Narrower conditions (5)
- Acute kidney injury
- Acute kidney tubular necrosis
- Chronic renal failure syndrome
- Uremia
- Uremic neuropathy
Trials (4,266)
- "Hypoxic vs. Aerobic Training in Chronic Kidney Disease
- "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"
- "Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"
- (TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery
- 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
- 12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.
- 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
- 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
- 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
- 20070360 Incident Dialysis
- 24 Hour Use of the Wearable Artificial Kidney
- 24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease
- 2D-speckle Tracking in Pediatric Renal Chronic Disease
- 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
- 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
- 4-7-8 Breathing for Fatigue and Sleep Management in Hemodialysis
- 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
- 8-week Pilot Study of Relaxation for Weight Loss in Adults With Chronic Kidney Disease
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
- A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants
Approved drugs (7)
- Benazepril hydrochloride
- Calcium acetate
- Captopril
- Dopamine hydrochloride
- Metoclopramide hydrochloride
- Quinapril hydrochloride
- Terlipressin
Drugs in development (103)
- Abiraterone acetate Phase 1
- Acetylcysteine Phase 1
- Adafosbuvir Phase 1
- Afatinib Phase 1
- Alefacept Phase 1
- Alemtuzumab Phase 1
- Alfacalcidol Phase 2
- Amino acids Phase 2
- Apixaban Phase 3
- Articaine Early phase 1
- Atorvastatin Phase 3
- Avadomide Phase 1
- Avibactam Phase 1
- Aztreonam Phase 1
- Bemiparin Phase 1
- Bersacapavir Phase 1
- Bicarbonate Phase 3
- Canagliflozin Phase 1
- Certoparin Phase 1
- Citric acid Phase 3
Other linked drugs (5)
- Ilepatril
- Mannitol
- Sodium thiosulfate
- Tacrolimus
- Voriconazole